子宫肌瘤对早孕期无创产前检测参数的影响
本研究为回顾性队列研究,比较有肌瘤(n=122)与无肌瘤(n=937)孕妇早孕期cfDNA-based NIPT特征。肌瘤组平均胎儿分数较低(10.0% vs 11.5%;P=.001),无肥胖者中不确定结果率较高(5.3% vs 1.5%;P=0.03)。肌瘤大小不影响NIPT指标。
要点
- 肌瘤组平均胎儿分数低于无肌瘤组(10.0% vs 11.5%;P=.001)。
- 无肥胖(BMI低于30)者中,肌瘤组不确定结果率高于无肌瘤组(5.3% vs 1.5%;P=0.03)。
- 肌瘤组总cfDNA浓度较高(P=.002),提示胎儿分数可能被稀释。
核心结论
- 子宫肌瘤与较低的胎儿分数相关,并且在无肥胖患者中与较高的不确定结果率相关,且不依赖于肌瘤大小。
研究设计与样本
- 回顾性队列研究,纳入接受早孕期cfDNA-based NIPT的孕妇,肌瘤组n=122,无肌瘤组n=937。
主要发现
- 肌瘤组平均胎儿分数低于无肌瘤组(10.0% vs 11.5%;P=.001)。
- 无肥胖(BMI低于30)者中,肌瘤组不确定结果率高于无肌瘤组(5.3% vs 1.5%;P=0.03)。
- 肌瘤组总cfDNA浓度高于无肌瘤组(P=.002),提示胎儿分数可能被稀释。
- 肌瘤大小不影响NIPT指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Uterine leiomyomas may affect the performance of cell-free DNA (cfDNA)-based noninvasive prenatal testing (NIPT). We conducted a retrospective cohort study of pregnant individuals with and without leiomyomas undergoing first-trimester cfDNA-based NIPT. Characteristics of NIPT in patients with leiomyomas (n=122) were compared with those in patients without leiomyomas (n=937). Mean fetal fraction was lower in patients with leiomyomas compared with patients without (10.0% vs 11.5%; P =.001); however, the rate of indeterminate results was different only in patients without obesity (body mass index [BMI] lower than 30) (5.3% vs 1.5%; P =0.03). Total cfDNA concentration was higher in patients with leiomyomas ( P =.002), suggesting possible dilution of the fetal fraction. Leiomyoma size did not affect NIPT metrics. In conclusion, uterine leiomyomas are associated with lower fetal fraction and, in patients without obesity, with a higher rate of indeterminate results independent of leiomyoma size.
引用
- Kolarova TR, Alderson A, MacKinnon H, et al. Effect of Uterine Leiomyomas on Noninvasive Prenatal Testing Parameters in the First Trimester. Obstet Gynecol. 2024. PMID: 38207338. doi:10.1097/AOG.0000000000005504
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。